In these 8 patients, verification was based on decreasing PSA levels after salvage radiotherapy of the prostate fossa or the pelvic lymph nodes (n = 3) or a follow-up PSMA PET/CT exhibiting tumor progression (n = 5). Here, FOLH1 is linked to neoplasm.